The Association of Number of Retrieved Lymph Nodes with Oncologic Outcomes in Patients with Papillary Thyroid Cancer with Lateral Cervical Nodal Metastasis

医学 节的 甲状腺乳突癌 甲状腺癌 淋巴 转移 肿瘤科 颈淋巴结 内科学 甲状腺 宫颈癌 癌症 放射科 病理
作者
Hye In Kim,Jung Hee Shin,Boram Kim,Mihyeon Jin,Nak Gyeong Ko,Jung Hwan Cho,Ji Min Han,Sunghwan Suh,Ji Cheol Bae,Jung‐Han Kim,Sun Wook Kim,Jae Hoon Chung,Tae Hyuk Kim,Ji Soo Kim
出处
期刊:Thyroid [Mary Ann Liebert]
卷期号:35 (11): 1311-1321
标识
DOI:10.1177/10507256251388093
摘要

Background: The number of retrieved lymph nodes (rLN) is an important surgical metric associated with survival in cancer. However, its association with oncological outcomes in patients with papillary thyroid cancer (PTC) with lateral lymph node (LN) metastasis (N1b disease) has not been investigated. Methods: This retrospective cohort study included patients with PTC and N1b disease (N = 1003) who underwent lateral neck dissection and categorized them by total number of rLNs. We investigated the association of the categories with recurrence or cancer-specific mortality (CSM) using multivariable Cox proportional hazard models. The optimal number of rLNs associated with low recurrence rate or CSM were identified using restricted cubic spline analysis. Survival analyses across subgroups were performed according to adequate (the estimated total number of rLN at which CSM appeared to be lowest) and inadequate groups. Results: At initial surgery, the median total number of rLNs and positive number of LNs was 36.0 (25.0-49.0) and 9.0 (5.0-14.0), respectively. During a median follow-up of 90.0 (73.0-129.0) months, recurrence and CSM were detected in 165 and 30 patients, respectively. A higher total number of rLNs was inversely associated with the adjusted hazard ratio (aHR) for recurrence (0.50, 0.51, 0.33, and 0.28; p for trend = 0.001) and CSM (0.33, 0.13, 0.02, and 0.04; p for trend 0.002). The estimated total number of rLNs associated with the lowest recurrence rate and CSM were 32 and 33, respectively. Compared with the inadequate rLNs group, the adequate rLNs group (≥33 total rLNs) showed better prognosis in the entire group (aHR 0.51 [0.35-0.73], p < 0.001; recurrence) (aHR 0.14 [0.04-0.47], p = 0.001; CSM) and various subgroups. Conclusions: rLNs are associated with recurrence and CSM in patients with PTC and N1b disease, with outcomes appearing to improve at approximately 32-33. This finding suggests that rLNs may serve as a potential quality indicator for neck dissection in PTC. Our finding is mostly applicable to more aggressive disease, and further prospective confirmatory research is warranted.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Katrina完成签到,获得积分10
1秒前
1秒前
jingutaimi完成签到,获得积分10
1秒前
ni发布了新的文献求助30
3秒前
尺素寸心发布了新的文献求助10
3秒前
五五乐发布了新的文献求助10
6秒前
欧斌完成签到,获得积分10
6秒前
zhoumo完成签到 ,获得积分10
6秒前
怡然的飞珍完成签到,获得积分10
7秒前
7秒前
SciGPT应助一一采纳,获得10
8秒前
77完成签到,获得积分10
8秒前
万能图书馆应助離殇采纳,获得10
9秒前
美少女壮士应助耶耶采纳,获得20
9秒前
10秒前
xujy完成签到,获得积分10
11秒前
快乐冬灵发布了新的文献求助10
11秒前
djshao应助科研小白采纳,获得10
12秒前
青花椒完成签到,获得积分10
15秒前
一岁一礼完成签到 ,获得积分10
16秒前
量子星尘发布了新的文献求助10
16秒前
沧海一声笑完成签到,获得积分10
17秒前
李彦完成签到,获得积分10
17秒前
19秒前
粥粥完成签到,获得积分0
19秒前
20秒前
阿绿完成签到 ,获得积分10
21秒前
西因应助青花椒采纳,获得10
21秒前
22秒前
中西西完成签到 ,获得积分10
23秒前
武汉第一牛马完成签到,获得积分10
24秒前
科目三应助晓晓采纳,获得10
24秒前
26秒前
科研通AI6应助单薄的咖啡采纳,获得10
26秒前
Xuan完成签到,获得积分10
27秒前
Green完成签到,获得积分10
27秒前
剁手党完成签到,获得积分10
28秒前
29秒前
30秒前
可爱语芹完成签到 ,获得积分10
30秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Agriculture and Food Systems Third Edition 2000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 临床微生物学程序手册,多卷,第5版 2000
人脑智能与人工智能 1000
King Tyrant 720
Silicon in Organic, Organometallic, and Polymer Chemistry 500
Principles of Plasma Discharges and Materials Processing, 3rd Edition 400
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5600631
求助须知:如何正确求助?哪些是违规求助? 4686248
关于积分的说明 14842519
捐赠科研通 4677270
什么是DOI,文献DOI怎么找? 2538898
邀请新用户注册赠送积分活动 1505830
关于科研通互助平台的介绍 1471207